Health & Fitness

According to FutureWise analysis, the hematology-oncology testing market in 2025 is US$3.95 billion and is expected to reach US$10.03 billion by 2033 at a CAGR of 12.35%. The term "hematologist oncologist" defines a specialized physician focused on treating blood cancers. Among various types of malignancies, hematologic cancers are alarmingly prevalent, ranking among the top ten for both occurrence and mortality. Fortunately, advancements in cancer genetics have empowered these specialists with more than just diagnostic tools. They can now accurately gauge patient prognosis, tailor the most effective treatments, and closely monitor therapeutic responses. When it comes to diagnosing non-malignant genetic disorders, peripheral blood lymphocyte cultures play a crucial role. To optimize cell division and ensure a rich supply of metaphases, phytohemagglutinin (PHA) is introduced into the culture media, enhancing the process. However, identifying cytogenetic ... Continue reading →

According to FutureWise analysis, the hematopoietic stem cell transplantation (HSCT) market in 2025 is US$3.37 billion, and is expected to reach US$7.52 billion by 2033 at a CAGR of 10.55%.  The hematopoietic stem cell transplantation (HSCT) market is experiencing significant growth, projected to increase from a notable US$3.37 billion in 2025 to an impressive US$7.52 billion by 2033. This reflects a robust compound annual growth rate (CAGR) of 10.55%. This exciting growth is primarily driven by the rising incidence of hematological malignancies such as leukemia, lymphoma, and multiple myeloma, along with the increasing adoption of HSCT for treating autoimmune disorders. Innovation plays a central role in this expansion, with advancements in HLA-typing technologies and improved protocols for managing graft-versus-host disease (GVHD) significantly enhancing both transplant success rates and patient outcomes. Furthermore, the growing accessibility of unrelated donor ... Continue reading →

According to FutureWise analysis, the hemoglobin a1c testing devices market in 2025 is US$2.86 billion, and is expected to reach US$6.39 billion by 2033 at a CAGR of 10.57%.  The global market for hemoglobin A1c testing devices is experiencing significant growth, primarily driven by the diabetes epidemic that affects over 500 million adults worldwide. Healthcare providers are increasingly adopting point-of-care A1c testing devices, which allow patients to receive rapid test results within minutes. This immediate feedback facilitates timely and informed treatment decisions during consultations. Additionally, there is a notable trend towards home-based diabetes management, leading to heightened demand for portable and user-friendly A1c testing devices. These tools enable patients to monitor their long-term glycemic control conveniently, reducing the need for frequent laboratory visits. Recent technological advancements, including smartphone integration and cloud-based data ... Continue reading →

According to FutureWise analysis, the Hemophilia B Market in 2025 is US$3.66 billion, and is expected to reach US$8.27 billion by 2033 at a CAGR of 7.21%.  The global Hemophilia B market is currently experiencing significant growth, primarily driven by innovative advancements in extended half-life factor IX therapies. These developments allow patients to require less frequent dosing, which greatly improves adherence to treatment and enhances their overall quality of life. In addition, gene therapy is emerging as a groundbreaking option, with several candidates in late-stage clinical trials, offering real hope for long-term or even curative solutions for individuals living with Hemophilia B. Furthermore, there is a notable shift from on-demand treatment to proactive prophylactic regimens. This proactive approach not only reduces the frequency of bleeding incidents but also minimizes long-term joint damage, paving the way for a healthier future for patients. Additionally, ... Continue reading →

According to FutureWise analysis the market for hernia repair devices and consumables in 2025 is US$ 5.99 billion, and is expected to reach US$ 8.02 billion by 2033 at a CAGR of 3.72%. The growth is fueled by the rising incidence of hernias, the adoption of minimally invasive surgeries, and advancements in mesh design that enhance patient outcomes. Demand for lightweight, biologic, and hybrid meshes is increasing as surgeons aim for quicker recovery and fewer complications. Expanding access to surgical care in emerging markets also offers long-term opportunities for manufacturers. Hernias arise when a portion of the abdominal lining protrudes through a weakened area in the abdominal muscles, forming a sac. This condition can manifest in various regions of the body, most commonly seen as umbilical hernias at the navel, inguinal hernias in the groin, or post-surgical hernias at an incision site from previous surgeries. The management of hernias can be approached in two primary ways: ... Continue reading →

According to FutureWise analysis the market for hernia repair in 2025 is US$ 4.87 billion, and is expected to reach US$ 6.79 billion by 2033 at a CAGR of 4.24%. The market is growing due to the rising incidence of abdominal and inguinal hernias and a preference for minimally invasive repair techniques. Technological advancements, such as biologic and composite meshes and robotic-assisted surgeries, are improving outcomes and encouraging adoption. Moreover, increased healthcare access in developing regions is driving procedural volumes and market demand. The market for hernia repair is anticipated to grow significantly due to the rising prevalence of obesity and a growing demand for innovative biological meshes. According to the National Center for Health Statistics (NCHS), more than 750,000 groin hernia treatments are performed annually in the United States. Among the various types of hernias, inguinal hernias are the most frequently diagnosed, affecting over 2% of women and more than ... Continue reading →

According to FutureWise analysis the market for herpangina treatment in 2025 is US$ 1.74 billion, and is expected to reach US$ 2.91 billion by 2033 at a CAGR of 6.64%. The market is growing due to the rising incidence among children, increasing viral outbreaks, and a higher demand for therapies that reduce symptoms and recovery time. Advancements in antiviral formulations and pediatric-focused OTC medications, along with improved diagnostic awareness, are enhancing adoption. Better healthcare access in emerging economies is also expanding treatment uptake and boosting overall market growth. Herpangina is a viral infection characterized by a high fever and blister-like sores in the mouth and throat. It tends to spread rapidly in environments such as daycare centers and schools, where children are in close proximity to one another. The symptoms of herpangina share similarities with those of hand, foot, and mouth disease, making it a notable concern for parents and caregivers of young ... Continue reading →

According to FutureWise analysis, the Herpes Labialis Treatment market in 2025 is US$1.15 billion, and is expected to reach US$1.80 billion by 2033 at a CAGR of 5.76%.  The Herpes Labialis Treatment market is experiencing significant growth, primarily due to the increasing prevalence of herpes simplex virus type 1 (HSV-1) infections worldwide. It is estimated that approximately 67% of the population under 50 years of age is affected by this virus, which greatly contributes to the rising demand for effective treatment options. The market is divided into three main categories: topical treatments, oral antivirals, and combination therapies. Among these, topical formulations currently hold the largest market share, primarily because of their ease of application and widespread availability without a prescription. Many individuals prefer these topical treatments for their convenience, allowing them to manage outbreaks with minimal hassle. Regionally, North America leads the ... Continue reading →

According to FutureWise analysis, the market for high flow needle sets in 2025 is US$ 1.17 billion and is expected to reach US$ 1.93 billion by 2033 at a CAGR of 6.46%. Demand is rising due to increased use of high-flow infusion and transfusion procedures in emergency care, oncology, and critical settings. Technological advances in needle design, such as improved flow efficiency and reduced discomfort, are boosting adoption. Additionally, the growing number of surgical procedures and expanding hospital infrastructure in emerging markets support steady growth. High flow needle sets have become a crucial element in contemporary clinical practice, particularly in environments where timely and efficient vascular access is essential. These specialized needle sets are designed to deliver higher flow rates compared to standard needles and are extensively utilized in fields such as emergency medicine, critical care, oncology, transfusion therapy, and various surgical procedures. Their ... Continue reading →

According to FutureWise analysis the market for high frequency chest-wall oscillation devices in 2025 is US$ 3.05 billion, and is expected to reach US$ 5.12 billion by 2033 at a CAGR of 6.69%. The market is expanding due to the rising prevalence of chronic respiratory diseases like cystic fibrosis and COPD, which necessitate effective mucus-clearance solutions. The growing use of home-based respiratory therapy, along with advancements in portable HFCWO systems, is driving demand. Moreover, digital monitoring and personalized therapy settings are improving patient compliance and increasing market uptake in clinical and homecare settings. High-Frequency Chest-Wall Oscillation (HFCWO) devices represent a significant advancement in respiratory care, providing an effective and non-invasive method for patients experiencing difficulties with airway clearance. Often referred to as “vest therapy systems,” these devices operate by delivering rapid air pulses through an inflatable ... Continue reading →